Summary
TIVDAK is used for the treatment of cervical cancer that has come back after
chemotherapy. Chemotherapy is a treatment that uses medicines to stop the growth of
cancer cells. This is done either by killing the cells or by stopping them from growing.
The purpose of this study is to learn about possible side effects of TIVDAK, specially to
any side effect that is related to the eye. A side effect is anything a medicine does to
your body that is not part of how the medicine treats disease.
- This study is seeking for participants who: Are willing to take all the required eye
tests
- Have not received TIVDAK before
- Do not have any active eye issues.
Participants will receive TIVDAK once every 3 weeks as an infusion that will be injected
into the vein. Participants will visit an eye care provider at 3 stages:
- before starting the treatment,
- before each of the first 9 infusions
- then monthly for 3 months after they stop taking TIVDAK. Treatment with TIVDAK will
continue until it is not working anymore against the participant's cancer.